AGIO (Agios Pharmaceuticals) Change In Inventory: $-5.48 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AGIO Agios Pharmaceuticals Inc AGIO
46 GF Score
Price $40.01
GF Value $85.74
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Agios Pharmaceuticals Change In Inventory?

Agios Pharmaceuticals AGIO +1.01% 46 Change In Inventory is $-5.48 Mil as of Mar. 2026. GuruFocus rates AGIO with a GF Score™ of 46/100 and a GF Value™ of $85.74 (Possible Value Trap). The stock has 5 warning signs investors should review.

Agios Pharmaceuticals's change in inventory for the quarter that ended in Mar. 2026 was $-2.17 Mil. It means Agios Pharmaceuticals's inventory increased by $2.17 Mil from Dec. 2025 to Mar. 2026 .

Agios Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2025 was $-5.30 Mil. It means Agios Pharmaceuticals's inventory increased by $5.30 Mil from Dec. 2024 to Dec. 2025 .

Agios Pharmaceuticals's Total Inventories for the quarter that ended in Mar. 2026 was $35.09 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Agios Pharmaceuticals's Days Inventory for the quarter that ended in Mar. 2026 was 2,352.40.

Inventory Turnover measures how fast the company turns over its inventory within a year. Agios Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Agios Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.64.

Agios Pharmaceuticals  (NAS:AGIO) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Agios Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=34.0035/1.319*365 / 4
=2,352.40

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Agios Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=1.319 / 34.0035
=0.04

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Agios Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=34.0035 / 20.746
=1.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agios Pharmaceuticals Change In Inventory Related Terms

Agios Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for Agios Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agios Pharmaceuticals Change In Inventory Chart

Agios Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -8.49 -10.58 -8.54 -5.30

Agios Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.99 -1.24 -1.19 -0.89 -2.17
AGIO
46GF Score
Agios Pharmaceuticals Inc AGIO
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agios Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-5.48 Mil mean?
Agios Pharmaceuticals (AGIO) has a Change In Inventory of $-5.48 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Agios Pharmaceuticals and its competitors.
Is Agios Pharmaceuticals' Change In Inventory too high?
Agios Pharmaceuticals' current Change In Inventory is $-5.48 Mil. Overall, Agios Pharmaceuticals has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Agios Pharmaceuticals' Change In Inventory compare to ABCL and KOD?
Agios Pharmaceuticals' Change In Inventory of $-5.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Agios Pharmaceuticals and its competitors. Agios Pharmaceuticals's current Change In Inventory is $-5.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agios Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Agios Pharmaceuticals (AGIO) is currently considered Possible Value Trap. The stock's GF Value™ is $85.74, compared to a current price of $40.01 — trading 53.3% below its estimated fair value. The current Change In Inventory is $-5.48 Mil. Agios Pharmaceuticals' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Agios Pharmaceuticals (AGIO), the current Change In Inventory is $-5.48 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agios Pharmaceuticals (AGIO) Overvalued in 2026?

Based on GuruFocus' analysis, Agios Pharmaceuticals stock appears to be undervalued. The current stock price of $40.01 is trading 53.3% below its estimated GF Value™ of $85.74. GuruFocus considers Agios Pharmaceuticals to be Possible Value Trap.

Key valuation signals for AGIO:

  • Change In Inventory: $-5.48 Mil
  • GF Value™: $85.74 vs. price of $40.01 (53.3% below fair value)
  • GF Score™: 46/100 with 5 warning signs

No single metric tells the full story. See the AGIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agios Pharmaceuticals Business Description

Other Exchanges 0HB0:UK8AP:Germany
Address 88 Sidney Street, Cambridge, MA, USA, 02139
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
46GF Score

Get the complete analysis for AGIO

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.01
Price
$85.74
GF Value